KARAN NEALEN: Open Payments
NPI 1063056836 · EBENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,728 in 149 payments from 20 companies in 2025. Trend: 2023 $770 · 2024 $665 · 2025 $2,728
Food & beverage: $2,728
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $389 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $245 |
| Novo Nordisk Inc | 18 | $240 |
| Phathom Pharmaceuticals, Inc. | 5 | $207 |
| PFIZER INC. | 13 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $183 |
| Exact Sciences Corporation | 8 | $176 |
| Ardelyx, Inc. | 9 | $166 |
| Verona Pharma, Inc. | 13 | $163 |
| Teva Pharmaceuticals USA, Inc. | 8 | $153 |
Products named: XIFAXAN, VOQUEZNA, NURTEC ODT, CAPLYTA, The Cologuard Plus Collection Kit, VRAYLAR, IBSRELA, Ohtuvayre.
Industry payments across PA — which companies pay providers there.
